Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
http://www.nejm.org/multimedia/audio-interview
NEJM Interview: Dr. Jerry Avorn on the FDA Amendments Act of 2007 and the effort to make data on drug safety more transparent and available.
Dr. Jerry Avorn is a professor of medicine at Harvard Medical School and a member of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn, A. Kesselheim, and A. Sarpatwari. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later. N Engl J Med 2018;379:1097-9.